Teledyne e2v releases 1.5 Megapixel version of Optimom, a turnkey optical module for quick and easy development of vision systems
Globe Newswire28-02-2023, 15:00
Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26